Medscape

Pneumococcal Conjugate Vaccine V116 Extends Protection to Adults Living With HIV

The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 ...
Infectious Disease Advisor

V116 Provides Safe, Effective, Broader Pneumococcal Protection in Patients With HIV

The adult-specific 21-valent pneumococcal conjugate vaccine was well tolerated and immunogenic across all 21 serotypes in patients with HIV infection.
Business Wire

NextPoint Therapeutics to Highlight Antibody-Drug Conjugate (ADC) and T Cell Engager (TCE) Preclinical Findings Targeting Novel B7-H7 Pathway at AACR Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--NextPoint Therapeutics, a clinical-stage biotechnology company launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7 ...
Medical Xpress

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrates encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), ...